Fasting Glucose Variability as a Risk Indicator for End-Stage Kidney Disease in Patients with Diabetes: A Nationwide Population-Based Study

Given the fact that diabetes remains a leading cause of end-stage kidney disease (ESKD), multi-aspect approaches anticipating the risk for ESKD and timely correction are crucial. We investigated whether fasting glucose variability (FGV) could anticipate the development of ESKD and identify the popul...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Da Young, Kim, Jaeyoung, Park, Sanghyun, Park, So Young, Yu, Ji Hee, Seo, Ji A., Kim, Nam Hoon, Yoo, Hye Jin, Kim, Sin Gon, Choi, Kyung Mook, Baik, Sei Hyun, Han, Kyungdo, Kim, Nan Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705330/
https://www.ncbi.nlm.nih.gov/pubmed/34945244
http://dx.doi.org/10.3390/jcm10245948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705330/
https://www.ncbi.nlm.nih.gov/pubmed/34945244
http://dx.doi.org/10.3390/jcm10245948

Ejemplares similares